Also found in: Wikipedia.
AMGENApplied Molecular Genetics (original meaning)
References in periodicals archive ?
Adjusted for costs associated with its acquisition of Abgenix, Amgen earned $1.
Under the terms of the agreement, Amgen will take responsibility for the further development and marketing of the therapeutic antibody candidates isolated by CAT against two targets on which the parties agreed to collaborate and will bear all the associated costs.
On October 18, 2002, the arbitrator found that Johnson & Johnson breached its license agreement with Amgen by promoting its brand of Epoetin alfa, Procrit, into Amgen's reserved dialysis market.
Amgen also announced today that the Board unanimously voted to amend the Company's bylaws to adopt a majority vote standard for the election of directors, beginning with the next election in May 2007.
Amgen executives said in a conference call that Fremont-based Abgenix's colorectal cancer drug panitumumab could eventually contribute $2 billion annually to its revenue stream, but didn't provide a timetable.
In the scope of the joint research agreement, Fresenius Medical Care and Amgen will facilitate a working group of European scientific experts in the renal field.
Amgen said the Roche units are importing an anti-anemia product called CERA that contains a product covered by its patents.
Under the agreement, Fresenius Medical Care will devote efforts to assist Amgen in disseminating scientific information regarding the treatment of anemia to nephrologists and other dialysis experts.
Amgen said the drug continues to gain market share in the dermatology and rheumatology marketplace.
Amgen created the Breakaway from Cancer initiative in 2005 as a complementary component to the company's sponsorship of the Amgen Tour of California, a world-class cycling event taking place in February.
One out of every 10 employees in Thousand Oaks works at Amgen, accounting for $759 million in local payroll every year.
Cytokinetics Incorporated (NASDAQ:CYTK) and Amgen (NASDAQ:AMGN) today announced a strategic collaboration to discover, develop and commercialize novel small-molecule therapeutics that activate cardiac muscle contractility for potential applications in the treatment of heart failure.